Status:
RECRUITING
Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this observational study is to evaluate whether polygenic risk score (PRS) assessment can help predict the onset of epithelial ovarian cancer in women aged over 18, comparing those with a ...
Eligibility Criteria
Inclusion
- For cases: women with a first-time diagnosis of histologically confirmed epithelial ovarian or fallopian tube cancer.
- For Controls women with no concomitant or past OC diagnosis.
Exclusion
- For both cases and controls: the presence of concurrent malignancies other from OC.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT06935344
Start Date
June 1 2025
End Date
December 1 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dipartimento Universitario di Scienze della Vita e Sanità Pubblica
Roma, Italia, Italy, 00168